We read with great interest the article by Leniz et al.1 The authors show how primary care continuity (PCC) is associated to lower total costs and might contribute to reduce hospital admissions and costs among people with dementia in their last year of life. This important study adds to previous data supporting the benefit of PCC. We already have evidence showing that PCC is associated with increased survival.2,3 Furthermore, PCC reduces hospitalizations,4,5 emergency department visits,5 and improves cancer screening, influenza vaccination, and comprehensive diabetes care.6 PCC allows for better health outcomes, producing greater patient and professional satisfaction, improving treatment adherence, and reducing costs. If PCC were a drug or a device, it would have an IA indication in all clinical guidelines. It is difficult to think of another measure that provides so much benefit. However, PCC is not a drug; it only requires planning and will. Scientific societies, medical associations, academic institutions, and patients’ associations should demand PCC.
- © British Journal of General Practice 2025
